Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force

For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and weight gain with some SUs have led to discussion on...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Bahendeka, Silver, Sahay, Rakesh, Ghosh, Sujoy, Md, Fariduddin, Orabi, Abbas, Ramaiya, Kaushik, Al Shammari, Sameer, Shrestha, Dina, Shaikh, Khalid, Abhayaratna, Sachitha, Shrestha, Pradeep K., Mahalingam, Aravinthan, Askheta, Mazen, A. Rahim, Aly Ahmed, Eliana, Fatimah, Shrestha, Hari K., Chaudhary, Sandeep, Ngugi, Nancy, Mbanya, Jean Claude, Aye, Than Than, Latt, Tint Swe, Akanov, Zhanay A., Syed, Abbas Raza, Tandon, Nikhil, Unnikrishnan, A. G., Madhu, S. V., Jawa, Ali, Chowdhury, Subhankar, Bajaj, Sarita, Das, Ashok Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838894/
https://www.ncbi.nlm.nih.gov/pubmed/29535952
http://dx.doi.org/10.4103/ijem.IJEM_556_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838894/
https://www.ncbi.nlm.nih.gov/pubmed/29535952
http://dx.doi.org/10.4103/ijem.IJEM_556_17

Ejemplares similares